WS #10486

From 500 msgs · 12 key-dev

Another Pfizer Seagen-sourced ADC stumbles in clinic, negative for Pfizer's oncology pipeline. Lilly bets on BioArctic's brain-penetrating tech, expanding neurology pipeline.

Pfizer ADC setback

Another Pfizer Seagen-sourced ADC stumbles in clinic, negative for Pfizer's oncology pipeline.

Lilly bets on BioArctic's brain-penetrating tech, expanding neurology pipeline.

Full world state #10486 →